Evidence map›Paper›PMID 33537303›Full record

ArticleFrontiers in cell and developmental biology2020

Enhanced Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by a Hybrid Hydroxylapatite/Collagen Scaffold.

Elisa Mazzoni, Chiara Mazziotta, Maria Rosa Iaquinta, Carmen Lanzillotti, Francesca Fortini, Antonio D'Agostino, Lorenzo Trevisiol, Riccardo Nocini, Giovanni Barbanti-Brodano, Andrea Mescola and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Revolutionizing bone healing: the role of 3D models.Cell regeneration (London, England) · 2025
    Review
  14. Article
  15. Mutanobactin-D, aInternational journal of molecular sciences · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Elisa MazzoniDepartment of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.
Chiara MazziottaDepartment of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.
Maria Rosa IaquintaDepartment of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.
Carmen LanzillottiDepartment of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.
Francesca FortiniMaria Cecilia Hospital, GVM Care & Research, Cotignola, Italy.
Antonio D'AgostinoDepartment of Surgical Odonto-Stomatological Sciences, University of Verona, Verona, Italy.
Lorenzo TrevisiolDepartment of Surgical Odonto-Stomatological Sciences, University of Verona, Verona, Italy.
Riccardo NociniDepartment of Surgical Odonto-Stomatological Sciences, University of Verona, Verona, Italy.
Giovanni Barbanti-BrodanoDepartment of Oncologic and Degenerative Spine Surgery, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Andrea MescolaCNR-Nanoscience Institute-S3, Modena, Italy.
Andrea AlessandriniCNR-Nanoscience Institute-S3, Modena, Italy.
Mauro TognonDepartment of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.
Fernanda MartiniDepartment of Medical Sciences, School of Medicine, University of Ferrara, Ferrara, Italy.
University of Ferrara · ITUniversity of Verona · ITIstituto Nanoscienze · ITIstituto Ortopedico Rizzoli · ITMaria Cecilia Hospital · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human bone marrow-derived mesenchymal stem cells (hBMSCs) and their derivative enhanced green fluorescent protein (eGFP)-hBMSCs were employed to evaluate an innovative hybrid scaffold composed of granular hydroxylapatite and collagen hemostat (Coll/HA). The cellular morphology/cytoskeleton organization and cell viability were investigated by immunohistochemistry (IHC) and AlamarBlue metabolic assay, respectively. The expression of osteopontin and osteocalcin proteins was analyzed by IHC and ELISA, whereas osteogenic genes were investigated by quantitative PCR (Q-PCR). Cell morphology of eGFP-hBMSCs was indistinguishable from that of parental hBMSCs. The cytoskeleton architecture of hBMSCs grown on the scaffold appeared to be well organized, whereas its integrity remained uninfluenced by the scaffold during the time course. Metabolic activity measured in hBMSCs grown on a biomaterial was increased during the experiments, up to day 21 (

Indexed as

boneexpressiongeneosteogenesisscaffold

Identifiers

PMID33537303
PMCPMC7849836
OpenAlexW3118759151

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.